InMode Ltd. (INMD) research

InMode Ltd.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Devices
Last price
$14.19
As of

InMode Ltd. (INMD): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-16.

As of . Source: SEC EDGAR filings for INMD. Method and limitations.

SHARE THIS CARD

Share the INMD intelligence card

A branded snapshot of INMD: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion INMD intelligence card preview
Post to X
LIVE TERMINAL

See INMD live in the terminal

Track INMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live INMD terminal, free

Active signals for INMD

FREE, NO ACCOUNT

Every signal on INMD, as it fires

You are seeing 5 of 18 signals recorded on INMD since 2026-05-29.

The five above all landed on 2026-09-06. The other 13 were recorded on 2 other days. 14 of the 18 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in INMD (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP M5425M103 · 2026Q2$35M0.05%,
MILLENNIUM MANAGEMENT LLCCUSIP M5425M103 · 2026Q2$25.6M0.01%,
CITADEL ADVISORS LLCCUSIP M5425M103 · 2026Q2$7.2M0.00%,
Point72 Asset Management, L.P.CUSIP M5425M103 · 2026Q2$4.3M0.00%,
D. E. Shaw & Co., Inc.CUSIP M5425M103 · 2026Q2$1.7M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP M5425M103 · 2026Q2$274K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, INMD

INMD against its peers

INMD's operating margin of 23.0% ranks in the 98th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.

MetricINMDPeer medianPercentilen
Revenue FY370M USD151M USD6920
Revenue YoY-6.2%n/an/a0
Gross margin78.5%62.9%7618
Operating margin23.0%-24.7%9820
Net margin25.3%-25.0%9320
Return on equity13.7%-25.5%9819

Peers (20): SIBN, CBLL, QDEL, SSII, ENOV, BBNX, AVNS, AORT, IART, KIDS, DCTH, SENS, TCMD, NPCE, MASS, CLPT, CV, RCEL, OFIX, VMD. Left out: LMRI (no annual filing), BWAY (period gap), NHNKF (no annual filing), OSSUY (no annual filing), MOBI (no annual filing). Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (INMD: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more INMD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to INMDand get the insider, 13F, options, and confluence read in one view.

Open the live INMD terminal, free